| View |
|
DRP-11935
|
Anastrozole
|
Atrozole
|
1mg
|
Film-Coated Tablet
|
Aromatase Inhibitor
|
Kwang Dong Pharmaceutical Co., Ltd.
|
korea
|
Initial
|
20 May 2022
|
20 May 2027
|
| View |
|
DRP-12005
|
Cefuroxime (As Sodium)
|
Cerosan
|
750mg
|
Powder For Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
27 May 2022
|
27 May 2027
|
| View |
|
DRP-11982
|
Salbutamol (as sulfate)
|
Salmuto
|
2 mg
|
Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial
|
25 May 2022
|
25 May 2027
|
| View |
|
DRP-11979
|
Salbutamol (as sulfate)
|
None
|
2 mg
|
Tablet
|
Selective beta-2-adrenoreceptor agonist
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial
|
25 May 2022
|
25 May 2027
|
| View |
|
DRP-11983
|
Bupivacaine
|
Bupicord
|
5 mg/mL
|
Solution for Injection (Intrathecal)
|
-
|
Intas Pharmaceuticals Limited
|
India
|
Initial
|
25 May 2022
|
25 May 2027
|
| View |
|
DRP-11973
|
Oxaliplatin
|
Unioxali 50
|
2 mg/mL (50 mg/25 mL)
|
Concentrate Solution for IV
Infusion
|
Antineoplastic agent
|
Admac Lifesciences
|
India
|
Initial
|
26 May 2022
|
26 May 2027
|
| View |
|
DRP-11974
|
Oxaliplatin
|
Unioxali 100
|
2 mg/mL (100 mg/50 mL)
|
Concentrate Solution for IV
Infusion
|
Antineoplastic agent
|
Admac Lifesciences
|
India
|
Initial
|
26 May 2022
|
26 May 2027
|
| View |
|
DRP-11909
|
Co-Amoxiclav
|
Genclav
|
625mg
|
Film-Coated Tablet
|
-
|
Yeluri Formulations Pvt. Ltd.
|
India
|
Initial
|
20 May 2022
|
20 May 2027
|
| View |
|
DRP-11908
|
Co-Amoxiclav
|
Genclav
|
1g
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-lactamase inhibitor)
|
Yeluri Formulations Pvt. Ltd.
|
India
|
Initial
|
20 May 2022
|
20 May 2027
|
| View |
|
DR-XY48034
|
Metronidazole
|
Polgyl
|
5 mg/ mL (500 mg/ 100 mL)
|
Solution for I.V. Infusion
|
Antibacterial /Antiprotozoal (Nitroimidazole Derivative)
|
Polifarma Ilac San. Ve Tic A.S.
|
Turkey
|
Initial
|
20 May 2022
|
20 May 2027
|
| View |
|
DRP-11965
|
Dobutamine (as hydrochloride)
|
Dobumak
|
50 mg/mL
|
Solution for Injection (IV)
|
Adrenergic and Dopaminergic Agent
|
Makcur Laboratories Limited
|
India
|
Initial
|
24 May 2022
|
24 May 2027
|
| View |
|
DR-XY48039
|
Telmisartan + Hydrochlorothiazide
|
Telmi HCT
|
80 mg/12.5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/Diuretic
|
Ajanta Pharma Limited
|
India
|
Initial
|
25 May 2022
|
25 May 2027
|
| View |
|
DRP-12001
|
Dopamine Hydrochloride
|
Dopam
|
40 mg/mL
|
Solution for Reconstitution (I.V. Infusion)
|
Adrenergic and Dopaminergic Agent
|
Sakar Healthcare Ltd.
|
India
|
Initial
|
27 May 2022
|
27 May 2027
|
| View |
|
DRP-11963
|
Dobutamine (As hydrochloride)
|
Dobufril-50
|
50 mg/ mL
|
Solution for Injection (IV)
|
Adrenergic and Dopaminergic Agent
|
Cooper Pharma Limited
|
India
|
Initial
|
24 May 2022
|
24 May 2027
|
| View |
|
DRP-11964
|
Dobutamine (As hydrochloride)
|
Dobufril-12.5
|
12.5 mg/ mL
|
Solution for Injection (IV)
|
Adrenergic and Dopaminergic Agent
|
Cooper Pharma Limited
|
India
|
Initial
|
24 May 2022
|
24 May 2027
|
| View |
|
DR-XY48067
|
Sevelamer Carbonate
|
Selaglob 800
|
800mg
|
Film-Coated Tablet
|
Drug for Treatment of Hyperkalemia/ Hyperphosphatemia
|
Globela Pharma Private Limited
|
India
|
Initial
|
30 May 2022
|
30 May 2027
|
| View |
|
DRP-11956
|
Pregabalin
|
Gabasyn
|
75 mg
|
Capsule
|
Antiepileptic
|
Sydenham Laboratories, Inc.
|
Philippines
|
Initial
|
24 May 2022
|
24 May 2027
|
| View |
|
DRP-11917
|
L- Asparaginase
|
Onconase 10
|
10,000 IU
|
Lyophilized Powder for Injection (IM/IV)
|
Antineoplastic
|
United Biotech Pvt. Ltd.
|
India
|
Initial
|
20 May 2022
|
20 May 2027
|
| View |
|
DRP-11994
|
Ondansetron (As Hydrochloride Dihydrate)
|
Onetic 8
|
2 mg/mL (8 mg/4 mL)
|
Solution for Injection (I.M./I.V.)
|
Antiemetic and Antinauseant
|
PT Pratapa Nirmala
|
Indonesia
|
Initial
|
27 May 2022
|
27 May 2027
|
| View |
|
DRP-11912
|
Ascorbic Acid
|
Max-cee
|
250mg/mL
|
Solution for Injection (IV/IM/SC)
|
Vitamin
|
Mason Pharma
|
india
|
Initial
|
20 May 2022
|
20 May 2025
|